Wildy logo
(020) 7242 5778

Wildy’s Book News

Book News cover photo

Vol 23 No 5 May/June 2018

Book of the Month

Cover of Drafting Commercial Agreements

Drafting Commercial Agreements

Price: £110.00

Offers for Newly Called Barristers & Students

Special Discounts for Newly Called & Students

Read More ...

Secondhand & Out of Print

Browse Secondhand Online


Lowe legislation jp
Sealy millman 2018 jp
Desmith out now
Luba housing
This book is now Out of Print.
A new edition has been published, the details can be seen here:
Rules and Guidance for Pharmaceutical Manufacturers and Distributors 2017 (The Orange Guide) isbn 9780857112859

Rules and Guidance for Pharmaceutical Manufacturers and Distributors 2015 (The Orange Guide)

Image not available lge
MHRAMedicines and Healthcare products Regulatory Agency

ISBN13: 9780857111715
New Edition ISBN: 9780857112859
Published: January 2015
Publisher: Pharmaceutical Press
Country of Publication: UK
Format: Paperback
Price: Out of print

This is the ninth edition of Rules and Guidance for Pharmaceutical Manufacturers and Distributors compiled by MHRA. Commonly known as the Orange Guide it remains an essential reference for all manufacturers and distributors of medicines in Europe.

It provides a single authoritative source of European and UK guidance, information and legislation relating to the manufacture and distribution of human medicines.

The new 2015 edition incorporates all the significant updates and additions to the detailed European Community guidelines on GMP since the last edition, including the revised EU Guidelines on Good Distribution Practice.

In addition, it contains new sections on:-

  • The Gold Standard for Responsible Persons
  • MHRA Innovation Office
  • The Application and Inspection process for new licences – "what to expect”
  • MHRA Compliance Management and Inspection Action Group
  • MHRA Risk-based inspection programme
  • Naming Contract Quality Control (QC) laboratories
  • GDP Quality Systems
  • A new flow chart on registration requirements for UK companies involved in the sourcing and supply of active substances (ASs), to be used in the manufacture of licensed human medicines
Building on the restructured contents and fresh redesign of the last edition, you’ll find all the answers you need to stay informed. The Orange Guide is compiled by the Inspection, Enforcement and Standards Division, MHRA, London, UK.

Image not available lge
Medical Law